ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 165 filers reported holding ROCKET PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,088 | +3563.2% | 101,928 | +2911.2% | 0.00% | – |
| Q1 2023 | $57 | -99.0% | 3,385 | +648.9% | 0.00% | – |
| Q2 2022 | $6,000 | -89.8% | 452 | -66.5% | 0.00% | – |
| Q1 2021 | $59,000 | +247.1% | 1,350 | +321.9% | 0.00% | – |
| Q4 2020 | $17,000 | -93.2% | 320 | -97.1% | 0.00% | – |
| Q3 2020 | $251,000 | +33.5% | 11,021 | +22.7% | 0.00% | – |
| Q2 2020 | $188,000 | +45.7% | 8,985 | -3.3% | 0.00% | – |
| Q1 2020 | $129,000 | +1742.9% | 9,294 | +1733.1% | 0.00% | – |
| Q2 2019 | $7,000 | -93.6% | 507 | -88.7% | 0.00% | – |
| Q3 2018 | $110,000 | +168.3% | 4,497 | +114.3% | 0.00% | – |
| Q2 2018 | $41,000 | – | 2,098 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $11,354,000 | 10.44% |
| RTW INVESTMENTS, LP | 15,802,802 | $250,632,000 | 5.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 63,000 | $17,884,000 | 4.03% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $20,077,000 | 4.02% |
| Prosight Management, LP | 203,268 | $3,224,000 | 2.08% |
| COWEN AND COMPANY, LLC | 1,000,000 | $15,860,000 | 1.53% |
| Boxer Capital, LLC | 1,466,051 | $23,252,000 | 1.20% |
| Cormorant Asset Management, LP | 868,550 | $13,775,000 | 1.06% |
| Amitell Capital Pte Ltd | 97,331 | $1,544,000 | 0.90% |
| SECTORAL ASSET MANAGEMENT INC | 303,975 | $4,821,000 | 0.86% |